Taken together, our study was not able to detect molecular differences between BA infants with different clinical outcomes but provides evidence for amyloidosis-related genes as potential contributors to BA pathogenesis and subsequent liver fibrosis, where APP could serve as a potential liquid biomarker. Here, APP is linked to Hepatic fibrosis.